Key hire
Dr Julie Cherrington Joins Xenome Board
Xenome appointed Dr Julie Cherrington, president of San Diego biopharmaceutical Phenomix and a Progen board member, as an independent director of the drug developer, effective 1 August 2009.
Chairman of the Board, Xenome
Jim Hazel
Roles
| Role | Organisation | Sources |
|---|---|---|
| Chairman of the Board | Xenome | GBS Ventures (25 May 2010), GBS Ventures (11 Aug 2009) |
Coverage
Stories naming Jim Hazel. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.